2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Crystal Arthropathies: new trials by email Literature Review of Crystal Arthropathies trials Research Report on Crystal Arthropathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment Lesinurad, XOI, Placebo - Gout, Chronic Kidney Disease (CKD) | Phase 4 | Terminated | Ironwood Pharmaceuticals, Inc. | 242 | 2017-07-19 | 2021-11-04 |
| Pharmacogenetics of SGLT2 Inhibitors Canagliflozin - Diabetes Mellitus, Gout | Phase 4 | Terminated | University of Maryland, Baltimore | 30 | 2015-06-01 | 2022-08-02 |
Gout (2) · Diabetes Mellitus (1) · Hyperuricemia (1) · Renal Insufficiency, Chronic (1)
Arthritis (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Joint Diseases (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Purine-Pyrimidine Metabolism, Inborn Errors (2) · Rheumatic Diseases (2) · Chronic Disease (1) · Disease Attributes (1)
Adrenal Cortex Hormones (1) · Allopurinol (1) · Canagliflozin (1) · Colchicine (1) · Febuxostat (1) · lesinurad (1)
Ironwood Pharmaceuticals, Inc. (1) · University of Maryland, Baltimore (1)
Czechia (1) · Hungary (1) · Poland (1) · United States (1)
R21DK105401 (1)